Stocks Health care RNXT
NASDAQ · Health careRenovoRx, Inc. (RNXT)
RenovoRx, Inc. brought in $2M of revenue over the twelve months to June 30, 2026. It posted a net loss of $12.3M. In fiscal 2025 capital spending exceeded operating cash flow by $11M. At June 30, 2026 it held $9.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What RenovoRx, Inc. does
RenovoRx, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker RNXT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.1M | -$11.2M | -$0.32 | -$11M |
| 2024 | $43K | -$8.8M | -$0.40 | -$9.1M |
| 2023 | n/a | -$10.2M | -$0.99 | n/a |
| 2022 | n/a | -$9.9M | -$1.09 | n/a |
| 2021 | n/a | -$6.3M | -$1.21 | n/a |
| 2021 | n/a | -$3.8M | -$1.72 | n/a |
Latest SEC filings
What RenovoRx, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 20, 2026Other event 8-K
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026Quarterly results 8-K/A
- August 12, 2026Exhibits 8-K
- August 4, 2026Other event 8-K
- July 2, 2026
- June 30, 2026
- June 30, 2026
- May 15, 2026Annual report (amended) 10-K/A · period to December 31, 2025
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about RNXT
What does RenovoRx, Inc. do?
RenovoRx, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker RNXT.
Is RenovoRx, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $12.3M on revenue of $2M.
How much revenue does RenovoRx, Inc. make?
Over the twelve months to June 30, 2026 RenovoRx, Inc. reported revenue of $2M.
When did RenovoRx, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 15, 2026.
Similar companies
Follow RNXT
Get an email when RenovoRx, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow RNXT: get an email when it filesWhere the numbers come from
Financial figures are the values RenovoRx, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.